6 months ago
CAPR
AnalystsBoobalan PachaiyappanBoobalan Pachaiyappan's Stock Forecasts
AnalystsBoobalan Pachaiyappan
Sectors:
Industries:
Analyst Ranking
Top 11%
#543 out of 5263 analysts
Average Return
+39.42%
Win Rate
60%18 out of 30
Risk vs Reward
Poor
Good
Boobalan Pachaiyappan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Capricor Therapeutics IncCAPR | +452.98% | $5.87 | $32.46 | 2025-11-11 - 2026-04-29 | Strong Buy |
Capricor Therapeutics IncCAPR | +339.54% | $7.39 | $32.46 | 2025-07-13 - 2026-04-29 | Strong Buy |
Capricor Therapeutics IncCAPR | +166.28% | $12.19 | $32.46 | 2025-06-16 - 2026-04-29 | Strong Buy |
Verona Pharma PLCVRNA | +136.53% | $45.20 | $106.91 | 2025-01-09 - 2025-10-07 | Strong Buy |
Cervomed IncCRVO | +105.93% | $2.36 | $4.86 | 2025-03-10 - 2026-03-10 | Strong Buy |
Boobalan Pachaiyappan Analyst Color
Get additional color on Boobalan Pachaiyappan's coverage of popular stocks
a year ago
CRVO
a year ago
CRVO
Boobalan Pachaiyappan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Reviva Pharmaceuticals Holdings IncRVPH | 3 | Strong Buy | $1.00 | +15.34% | Maintains | a month ago |
Cingulate IncCING | 5 | Strong Buy | $14.00 | +197.24% | Maintains | a month ago |
Cervomed IncCRVO | 5 | Strong Buy | $11.00 | +201.37% | Maintains | a month ago |
Neurosense Therapeutics LtdNRSN | 1 | Strong Buy | $3.00 | +273.60% | Initiates Coverage On | 2 months ago |
Ovid Therapeutics IncOVID | 1 | Strong Buy | $3.00 | +11.52% | Initiates Coverage On | 5 months ago |
Polypid LtdPYPD | 3 | Strong Buy | $9.00 | +98.68% | Maintains | 6 months ago |
Capricor Therapeutics IncCAPR | 3 | Strong Buy | $13.00 | -59.95% | Maintains | 6 months ago |
Avidity Biosciences IncRNAM | 1 | Strong Buy | $62.00 | +320.34% | Initiates Coverage On | 7 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $3.00 | +246.42% | Maintains | 8 months ago |
Gain Therapeutics IncGANX | 3 | Strong Buy | $6.00 | +240.91% | Maintains | 9 months ago |
Verona Pharma PLCVRNA | 2 | Strong Buy | $116.00 | +8.50% | Reiterates | 10 months ago |
Entrada Therapeutics IncTRDA | 1 | Strong Buy | $29.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.